in vivo PTHrP may be a key element in local control of the invasive process during breast carcinoma development and William J.Burtis 2,3 and that its role may be, in turn, dependent upon the
Introduction
Concord, MA, USA Parathyroid hormone-related peptide (PTHrP*) is a 139-173 4 To whom correspondence should be addressed amino acid protein, initially identified as the agent of the It has been previously reported that 8701-BC cells, derived humoral hypercalcemia of malignancy (HHM) syndrome (for from a primary carcinoma of the breast, constitutively a review see 1), likely evolved by duplication of the gene for express parathyroid hormone (PTH)-related peptide parathyroid hormone (PTH) and sharing amino acid sequence (PTHrP) and PTH/PTHrP receptor (PTH/PTHrP-R) genes, homology with the latter at its extreme N-terminus, thereafter that N-terminal, mid-regional and C-terminal immunoreacdiverging completely (2). Human N-terminal PTH and PTHrP tive PTHrP can be found in cell conditioned medium and, have been proven to bind to the same G protein-linked receptor furthermore, that exogenously added PTHrP (1-34), (67-(PTH/PTHrP-R; 3), thereby stimulating hypercalcemia and 86) and, to a minor extent, (107-139) are anti-mitogenic hypophosphatemia via the protein kinase A and phospholipase but promote Matrigel invasion by this cell line. It has also C intracellular signalling pathways with equal efficacy and been reported that PTHrP gene expression is selectively efficiency (for a review see 4). In addition to the studies switched on in those 8701-BC clonal lines endowed with a describing PTHrP as a HHM-associated factor, this hormonehigher proliferation rate and invasive ability in vitro. Here like molecule has been identified at the mRNA and/or protein we have first examined the presence of PTH/PTHrP-R level in a wide variety of normal tissues and cultured cells transcript in the different 8701-BC clones by PCR and (for a review see 5). Moreover, emerging evidence (for reviews Southern blot analysis. Second, we have studied the growth see 2,6) has indicated that full-length PTHrP may be a precursor and invasive response in vitro to PTHrP fragments by some protein undergoing proteolytic processing, possibly tissueof these clones, i.e. BC-3A, BC-61 and BC-66, selected on specific, into several smaller peptides ('bioactive' forms), the basis of their lower (BC-3A) or higher (BC-1 and BCsome of which have been immunodetected or isolated from 66) Matrigel invasion ability and their expression of PTHrP conditioned media of normal and neoplastic cells (see for (positive for BC-61and BC-66) and PTH/PTHrP-R (positive example 7-10). The polyproteic and almost ubiquitous nature for BC-61). Our data show the existence of clonal heterogenof PTHrP has therefore led to the concept that this protein eity for PTH/PTHrP-R mRNA and for the proliferative may function as a local autocrine/paracrine factor by exerting and invasive responses elicited by treatment with diverse PTH-and non-PTH-like effects on cell growth and differentiPTHrP fragments. In particular: (i) the sensitivity to ation through both PTH/PTHrP-R and another still unknown PTHrP (1-34) is restricted due to the uneven expression receptor(s) (for reviews see 2,4). To support this hypothesis, of PTH/PTHrP-R; (ii) BC-3A cells (the less 'aggressive' a broad spectrum of growth factor-like roles played by PTHrP clone) are resistant to the anti-mitogenic effect of the has been described (see for example 2,10-17). Interestingly, PTHrP domains and, most noticeably, exhibit a growth- Henderson et al. (18) have produced evidence that PTHrP potentiating response to PTHrP (67-86) opposite to that may also act as an intracrine factor, i.e. a factor operating in found for both the parental 8701-BC cells and the two an autocrine manner in the absence of extracellular secretion, other clones; (iii) all PTHrP fragments tested induced the thus by-passing the requirement for binding to cell surface expression of a growth-restraining and invasion-promoting receptors. phenotype by BC-61 cells (one of the more 'aggressive ' PTHrP is expressed at a very low level by normal human clones). Present data in vitro support the hypothesis that breast epithelium (19) and its expression appears to be enhanced in the lactation-linked proliferative and secretory states of duct (27) have isolated a number of cloned cell lines from the parental 8701-BC line by selective growth in agar and found that PTHrP expression is restricted to those clones endowed with higher proliferative and invasive properties in vitro. Altogether, these data prompted further investigation of the pattern of cell-hormone interactions within the heterogeneous 8701-BC tumour cell population, by analysis of the growth and invasive response to PTHrP fragments of clonal sublines from the parental 8701-BC line selected on the basis of their different phenotypical expressions, such as proliferation rate, invasive behaviour in vitro and PTH-and PTH/PTHrP-R expression.
Materials and methods

Cell cultures
The tumour cell line 8701-BC, derived from a biopsy fragment of a primary d.i.c. of the breast (29, 31) , and clones derived from the parental line by selective growth in 0.3% (BC-3A, BC-3D, BC-3E, BC-3F, BC-3H and BC-3I) or 0.6% agar (BC-61, BC-64, BC-65 and BC-66) (27) were cultured in RPMI 1640 medium (Gibco, Paisley, UK) with 10% fetal calf serum (FCS; Gibco) and antibiotics (100 U penicillin and 100 µg streptomycin/ml) at 37°C in a 3% CO 2 atmosphere. 8701-BC cells were at passages 22-28. BC-3A, BC-3D, BC-3E, BC-3F, BC-3H and BC-3I cells were at passages 79-89, 69, 
Intermediate performed using a 571 bp PTH/PTHrP-R probe, corresponding to bp 131-a parallel set of assays, the following enzyme inhibitors were individually added to the cell suspension 30 min before plating on Matrigel-coated filters: 702 of the human PTH/PTHrP-R mRNA (accession no. L04308), cloned into pBluescript (a gift from Dr D.Evans, Ciba-Geigy, Basel, Switzerland) and soybean trypsin-like enzyme inhibitor (STI) (100 µg/ml); tissue inhibitor of metalloproteinases (TIMP)-1 (10 µg/ml) (36); human urokinase-plasminogen labelled with [α-32 P]dCTP (sp. act. 3000 Ci/mmol) by random priming (Boehringer). Electrophoresed PCR products were blotted onto Hybond N activator (uPa)-neutralizing mAb 5B4 (prepared by Prof. F.Blasi; working dilution 1:200) specific for the EGF and kringle domains of uPa A chain (Amersham), prehybridized for 2 h at 42°C in 40% formamide, 5ϫ SSC, 50 mM phosphate buffer, pH 7, 1ϫ SDS, 10ϫ Denhardts and 200 µg/ml containing the uPa receptor binding site (37 and references therein). STI was purchased from Sigma, whilst TIMP-1 and mAb 5B4 were kind gifts of Dr denatured salmon sperm DNA (Sigma) and incubated overnight at 42°C with the denatured labelled probe (5ϫ10 7 c.p.m./membrane), added directly to the H.Nagase (University of Kansas Medical Center, KS) and Prof. Mario Del Rosso (Istituto di Patologia Generale, Università di Firenze, Firenze, Italy) prehybridization mix. After incubation, membranes were washed three times in 0.2ϫ SSC, 1% SDS at 60°C for 20 min and exposed to X-Omat film respectively. We have already reported that the inhibitors at the concentrations used are not cytotoxic and do not affect general cell motility as judged by (Kodak) with an intensifying screen at -70°C. chemotaxis assay (10).
PTHrP radioimmunoassay
Evaluation of 'in vitro' proliferation and invasion parameters Subconfluent cell cultures were washed with phosphate-buffered saline (PBS) and then incubated with serum-free RPMI medium and harvested after 24 h, Cell proliferation. The percentage cell number variation was calculated as centrifuged and lyophilized until submitted to a dosage of iPTHrP in cell (C 1 -C 0 /C 0 )ϫ100 medium using a C-terminal-specific RIA as described by Burtis et al. (34) . This employed antiserum R-22 prepared in rabbit and specific for Tyr109-where C 1 and C 0 were the cell numbers in response to treatment and in the PTHrP (109-138) (working dilution 1:2500) and [ 125 I]PTHrP (109-138) as parallel control assay respectively. radioligand dissolved in 0.1% Triton X-100, 0.1% bovine serum albumin (BSA)/PBS, the radioactivity being measured in both the pellet and the Cell invasion. The invasion index (II) and relative invasion index (RII) were supernatant after phase separation with dextran-coated charcoal. The sensitivity calculated from the following formulae: of the assay was 2.3 pM. Serum-free RPMI medium was used as control.
II ϭ C MGϩ /C MG-ϫ100 Proliferation assay Cells were plated at a concentration of 2.5ϫ10 4 /well on 4-well plastic dishes C MGϩ and C MG-being the numbers of migrated cells in parallel chemoinvasion (Nunc, Roskilde, Denmark) in 10% FCS/RPMI. After overnight incubation and chemotaxis tests respectively; to allow adhesion, cells were cultured with serum-free RPMI medium, with RII ϭ II 1 /II 0 either PTHrP (1-34), (67-86) amide or (107-138) (obtained from Peninsula, Belmont, CA) at different concentrations. After a 1 day culture, the medium II 1 being the invasion index using a chemoattractant and II 0 that in a parallel was replaced with a fresh one of the same composition and, after a further control assay. RII values of Ͻ1, 1 and Ͼ1 were indicative of invasion-24 h, the cells were trypsinized and counted with a haemocytometer. Each restraining, invasion-ineffective and invasion-promoting action of the chemoassay was done at least in triplicate.
attractant tested (10,38).
Chemotaxis assay Statistics Cell chemotactic behaviour was evaluated using a modified Boyden chamber
Results are given as means Ϯ SEM. Statistical differences between control test (35) , employing polyvinylpyrrolidone-free polycarbonate filters (13 mm and experimental values within the same set of assays were evaluated by filter diameter, 8 µm pore diameter; Nucleopore, Pleasanton, CA) and 'blind Student's t-test. The experimental design and procedure followed those described for the chemotaxis assay. In cloned cell subpopulations, we decided to choose three different cell prototypes for subsequent biological analyses, BC-3A, BC-61 and BC-66, whose properties are summarized in Table I . To check whether PTHrP was actually released into the CM of the latter two clones expressing PTHrP message (27) and also whether any quantitative difference in PTHrP release was detectable, both BC-61 and BC-66 cells were tested for iPTHrP presence in the CM, utilizing a RIA specific for a C-terminal peptide fragment which has been proven to give reliable and steady results with 8701-BC cells (10). The results obtained in triplicate experiments performed on CM from non-confluent cultures of BC-61 and BC-66 cells, assayed in parallel with parental 8701-BC cells at the same cell density, indicated the presence of C-terminal iPTHrP at concentrations of 2.00 Ϯ 0.40, 1.80 Ϯ 0.75 and 1.70 Ϯ 0.60ϫ10 -8 pmol/cell respectively (values not different at the 0.05 level).
Proliferative and invasive response of BC-61, BC-66 and BC-3A cells to PTHrP
The panel in Figure 2 shows the growth behaviour of BC-3A, BC-61 and BC-66 cells in the presence of PTHrP (1-34) (Figure 2A ), (67-86) ( Figure 2B ) and (107-138) ( Figure  2C ) at different concentrations. As expected from their exclusive expression of PTH/PTHrP-R, only BC-61 cells displayed a prominent growth-restraining response to PTHrP (1-34). On the other hand, the mid-regional and C-terminal PTHrP domains exerted anti-proliferative effects on both 0.6% agar clones. In particular, BC-61 and BC-66 cells exhibited growth inhibition at 10 and 100 pM concentrations of PTHrP (67-86) respectively, the inhibition being dosedependent down to 1 nM for the former clone, whilst remaining steady for the latter (~-55 and -64% respectively). On the other hand, the growth-restraining pattern of BC-61 and BC-66 cells in response to C-terminal PTHrP was similar, the inhibition being evident at 1 pM and reaching a plateau at 10 pM (~-68% and -69% respectively). Conversely, the BC-3A clone, whose growth rate was in no way influenced by PTHrP (107-138), exhibited a proliferative promotion of up to ϩ36% of cells in the presence of 1 nM PTHrP (67-86).
We then checked the chemoattractive potential of individual PTHrP fragments by evaluation of the RII valuess of the BC-3A, BC-61 and BC-66 cell lines. Before submission to PTHrP treatment, we examined the invasive behaviour of BC-66 cells under standard conditions and, as expected from their common origin by 0.6% agar cloning, they exhibited similar invasive behaviour and II values to those of BC-61 cells (see Table I ). From the evaluation of RII (Table  II) , a parameter which distinguishes invasive stimulation from the more extensive phenomenon of cell mobilization, all the PTHrP fragments tested at 1 nM appeared to elicit a prominent invasive response by BC-61 cells. On the other hand, BC-3A and BC-66 cells exhibited a Ͼ2-fold increase in their II with the mid-regional PTHrP fragment, whilst The first set of experiments reported here has demonstrated commonly associated with the progression of most solid non-homogeneous expression of PTH/PTHrP-R by the 8701-tumours. As extensively reviewed in the classical paper by BC clones examined, thus suggesting the existence of intratumHeppner (39) , this feature of neoplastic evolution, which is oural heterogeneity for this protein within the parental cell under the control of both genetic and epigenetic factors, is line, in addition to that already detected for PTHrP mRNA correlated with the development of novel cell subpopulations (27). As reported in the Results, on the basis of their different endowed with higher carcinogenic potential, capable of escapbiological properties (see Table I ) we have therefore selected ing the host's natural defences and of metastasizing to distant three clones, BC-3A, BC-61 and BC-66, for subsequent tissues. Consequently, the isolation of cell variants with differfunctional analyses. No difference in C-terminal iPTHrP secreent malignant behaviour and the identification of distinctive tion was found between the two PTHrP-expressing clones or heterogeneity markers has been one of the goals of modern between them and the parental line, suggesting a phenotypic cancer cell biology. It is also recognized that in vivo cells stability of the cultures for this biosynthetic activity. Obviously, interact with each other and with the surrounding microenvironthis does not exclude cell-cell, cell-ECM and cell-factor ment, generating a complex signalling framework within the interactions in vivo regulating the rate of PTHrP release by neoplastic microecosystem. The roles of extracellular matrix producer cell colonies. (ECM) structures and composition and of autocrine/paracrine
The second group of data has shown that the heterogeneity soluble modulators on tumour cell gene expression in the found by mRNA expression analysis is also reflected in the various stages of human cancers, including breast carcinoma, functional assays: if compared with the growth-restraining and has been reported in a number of experimental studies (for invasion-promoting influence exerted on parental 8701-BC reviews see [40] [41] [42] ; in particular, microenvironmental factors have been proven to critically control the fine tuning of growth cells, incubation with PTHrP fragments induces a different 
